Skip to main content

Table 1 a. Changes in HBsAg, HBeAg and HBV DNA prevalence with time in carriers detected between 1–4 years of age

From: Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia

 

Years after recruitment

Serological markers

0

5

9

19

HBsAg sero positivity (%)

68/68* (100)

42/60 (70.0%)

33/47 (70.2%)

37/53 (70.0%)

HBeAg seropositivity (%)

57/68* (83.8%)

25/42 (59.5%)

12/33 (36.3%)

5/53 (13.6%)

HBV DNA positive

62/62* (100%)

15/24 (62.5%)

20/39 (60.6%)

30/34 (88.2%)

b)

    

HBeAg positive carriers

 

0

5

9

19

Those with detectable HBV DNA

46/46 (100%)

9/9 (100%)

6/7 (85.7%)

5/5 (100%)

Those with viral load > 105 copies/mL)

46/46 (100%)

9/9 (100%)

6/7 (85.7%)

5/5 (100%)

Geometric Mean HBV DNA (copies/mL)

4.5 × 108

1.1 × 108

4.4 × 108

8.4 × 108

Median HBV DNA (copies/mL)

1.0×109

3.5×108

1.5×109

5.0×108

IQR (copies/mL)

5.0 × 108–2.0 × 09

5.0 × 107–6.5 × 108

5.5 × 108–6.5 × 109

4.0 × 108–2.5 × 109

c)

    

HBeAg negative carriers

 

0

5

9

19

Those with detectable HBV DNA

11/11 (100%)

2/7 (28.6%)

10/14 (71.4%)

28/31 (90.3%)

Those with high viral load (> 105 DNA copies/mL)

2/11 (18.2%)

1/7 (14.2%)

1/14 (7.1%)

3/31 (9.6%)

Geometric mean HBV DNA (copies/mL)

7.7 × 107

2.1 × 108

1.8 × 103

4.2 × 103

Median HBV DNA IQR (copies/mL)

2.0 × 104

2.0 × 105

2.0 × 103

1.0 × 103

IQR (copies/mL)

5.0 × 103–8.0 × 104

**3.6 × 104–5.2 × 108

1.0 × 103–1.0 × 104

4.0x × 102-7.5 × 103

  1. *The p-values for difference in prevalence between the first two time points are < 0.006 for HBsAg, < 0.001 for HBeAg and HBV DNA respectively.**One carrier who is HBeAg negative had high serum DNA level (5.2 × 108) at the second follow up point.